GE Healthcare expands cell therapy portfolio with license of ...

GE Healthcare will commercialize cGMP-grade versions of STEMCELL Technologies' T-Cell reagents for the isolation, activation, and culture of T-cells in ...

Newsroom | GE Healthcare

The latest Press Releases & GE Healthcare Reports.

Cytiva on X: "GE Healthcare expands #cell #therapy portfolio with ...

GE Healthcare expands #cell #therapy portfolio with license of STEMCELL Technologies' T-Cell reagents https://t.co/UvkIjv6TXH.

SOFIE and GE HealthCare Enter Licensing Agreement

Based on this agreement, GE HealthCare will take on global rights for [68Ga]FAPI-46 and outside-US rights for [18F]FAPI-74, originally developed ...

GE Healthcare Adds to Its Cell Therapy Portfolio with Acquisition of ...

GE Healthcare recently announced the acquisition of British cryogenic processing company Asymptote for an undisclosed price, strengthening its cell therapy ...

GE Healthcare Life Sciences, CDI announce license agreement

Per the terms of the agreement, GEHealthcare has licensed Cellular Dynamics to develop, manufacture and sellcellular assays and models derived ...

SOFIE and GE HealthCare Enter Licensing Agreement to Develop ...

11, 2023-- GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia , U.S. -based ...

GE Healthcare | GE News

GE Healthcare expands cell therapy portfolio with license of STEMCELL... IMAGE/PNG. ·. 0.21 MB. Press Release. GE Healthcare and Sealed Air ...

Licensing, IP, and Legal Archives - Page 56 of 58 - Scientific ...

Industrial Licensing, IP, and Legal · GE Healthcare expands cell therapy portfolio with license of STEMCELL Technologies' T-Cell reagents. Chalfont St Giles ...

GE Healthcare Life Sciences and Promosome sign licensing ...

GE Healthcare recently acquired Thermo Fisher's HyClone™ cell culture media and sera allowing GE to expand its offering of start-to-finish ...

N/A | GE News - General Electric

... cellular immunotherapies. business unit. GE Healthcare. tags. Products & Services · GE Healthcare expands cell therapy portfolio with license of STEMCELL...

GE Healthcare Adds to Its Cell Therapy Portfolio by Acquiring ...

The company's integrated suite of cryochain hardware, software, and consumables is designed to support cGMP and maintain the potency of cellular ...

GE Healthcare expands oncology PET tracer portfolio

As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in ...

GE Healthcare and Cell Technologies Fact Sheet

GE Healthcare has a portfolio of stem cell extraction and processing tools for such cellular therapy and research. The Celution® Systemii, licensed from ...

GE HealthCare takes key role in new consortium to revolutionize ...

“We are thrilled to play a leading role in Thera4Care, a unique collaboration of academic and industry partners who share a common goal to ...

Cell & Gene Therapy Commercial Insight – July 2016 - BioInsights

Celyad a company specialized in the development of engineered cell therapies, has entered into an exclusive license agreement with Japanese ...

GE Healthcare Fact Sheet - About Us

Between 2010 and 2020, GE Healthcare plans to invest over $500 million in research into neurological disorders. The investment crosses all lines of GE ...

CAR-T cell expansion platforms yield distinct T cell differentiation ...

With investigators looking to expand engineered T cell therapies such as CAR-T to new tumor targets and patient populations, a variety of cell manufacturing ...

GE HealthCare expands medical imaging equipment production

GE HealthCare expands Waukesha medical imaging equipment operation. It's part of personalized medicine ... GE HealthCare says it's now ...

Cell Therapy: Types, Regulation, and Clinical Benefits - PMC

Following the steps of their predecessor cell therapies that have become established or commercialized, investigational and premarket approval-exempt cell ...